Literature DB >> 9151761

An escalating dose/multiple high-dose binge pattern of amphetamine administration results in differential changes in the extracellular dopamine response profiles in caudate-putamen and nucleus accumbens.

R Kuczenski1, D S Segal.   

Abstract

Amphetamine (AMPH)-induced psychosis is most frequently associated with a chronic high-dose "binge" or "run" pattern of stimulant abuse, generally preceded by a period of gradually escalating doses of the drug. We showed previously that animals subjected to such a regimen of AMPH administration developed, over multiple daily binges, a unique pattern of behavioral response that included a decrease in stereotypy and a pronounced increase in locomotion. Because of the involvement of mesolimbic and mesostriatal dopamine (DA) pathways in locomotion and stereotypy, respectively, we hypothesized that a persistent shift in the relative magnitude of caudate-putamen (CP) and nucleus accumbens (NAC) DA transmission may contribute to this altered behavioral profile. To test this hypothesis, we examined CP and NAC extracellular DA in response to multiple high-dose AMPH binges. Our results revealed that with multiple binges the CP DA response but not the NAC response developed a profound tolerance/tachyphylaxis to the drug-induced increase in extracellular transmitter. These differential regional response alterations seem to correspond to the shift in the relative expression of stereotypy and locomotion. We hypothesize that changes in DA synthesis, perhaps mediated by regionally specific adaptations in DA autoreceptor function, contribute to the differential extracellular transmitter response profiles, and suggest that these neurochemical changes may have important implications for the mechanisms underlying the addictive and psychotogenic properties of AMPH.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9151761      PMCID: PMC6573531     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  47 in total

1.  A comparison between three methods for estimation of extracellular concentrations of exogenous and endogenous compounds by microdialysis.

Authors:  L Ståhle; S Segersvärd; U Ungerstedt
Journal:  J Pharmacol Methods       Date:  1991-03

2.  Acute administration of amphetamine: differential regulation of dopamine synthesis in dopamine projection fields.

Authors:  C B Tyler; M P Galloway
Journal:  J Pharmacol Exp Ther       Date:  1992-05       Impact factor: 4.030

3.  Contrasting effects of repeated treatment vs. withdrawal of methamphetamine on tyrosine hydroxylase messenger RNA levels in the ventral tegmental area and substantia nigra zona compacta of the rat brain.

Authors:  Y Zhang; J A Angulo
Journal:  Synapse       Date:  1996-11       Impact factor: 2.562

4.  Determination of brain interstitial concentrations by microdialysis.

Authors:  H Benveniste; A J Hansen; N S Ottosen
Journal:  J Neurochem       Date:  1989-06       Impact factor: 5.372

5.  Individual differences in responsiveness to single and repeated amphetamine administration: behavioral characteristics and neurochemical correlates.

Authors:  D S Segal; R Kuczenski
Journal:  J Pharmacol Exp Ther       Date:  1987-09       Impact factor: 4.030

6.  Selective 6OHDA-induced destruction of mesolimbic dopamine neurons: abolition of psychostimulant-induced locomotor activity in rats.

Authors:  P H Kelly; S D Iversen
Journal:  Eur J Pharmacol       Date:  1976-11       Impact factor: 4.432

7.  Continuous amphetamine intoxication: an animal model of the acute psychotic episode.

Authors:  G D Ellison; M S Eison
Journal:  Psychol Med       Date:  1983-11       Impact factor: 7.723

8.  Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: repeated administration.

Authors:  D J Henry; M A Greene; F J White
Journal:  J Pharmacol Exp Ther       Date:  1989-12       Impact factor: 4.030

9.  Biphasic effects of amphetamine on striatal dopamine dynamics.

Authors:  R Kuczenski
Journal:  Eur J Pharmacol       Date:  1977-12-01       Impact factor: 4.432

10.  Amphetamine levels in brain microdialysate, caudate/putamen, substantia nigra and plasma after dosage that produces either behavioral or neurotoxic effects.

Authors:  P Clausing; B Gough; R R Holson; W Slikker; J F Bowyer
Journal:  J Pharmacol Exp Ther       Date:  1995-08       Impact factor: 4.030

View more
  8 in total

1.  A threshold neurotoxic amphetamine exposure inhibits parietal cortex expression of synaptic plasticity-related genes.

Authors:  J F Bowyer; A R Pogge; R R Delongchamp; J P O'Callaghan; K M Patel; K E Vrana; W M Freeman
Journal:  Neuroscience       Date:  2006-10-13       Impact factor: 3.590

2.  The metabotropic glutamate 2/3 receptor agonist LY379268 blocked nicotine-induced increases in nucleus accumbens shell dopamine only in the presence of a nicotine-associated context in rats.

Authors:  Manoranjan S D'Souza; Matthias E Liechti; Ana M Ramirez-Niño; Ronald Kuczenski; Athina Markou
Journal:  Neuropsychopharmacology       Date:  2011-06-08       Impact factor: 7.853

Review 3.  Understanding the effects of stimulant medications on cognition in individuals with attention-deficit hyperactivity disorder: a decade of progress.

Authors:  James Swanson; Ruben D Baler; Nora D Volkow
Journal:  Neuropsychopharmacology       Date:  2010-09-29       Impact factor: 7.853

Review 4.  Associative and sensorimotor cortico-basal ganglia circuit roles in effects of abused drugs.

Authors:  C M Gremel; D M Lovinger
Journal:  Genes Brain Behav       Date:  2016-08-26       Impact factor: 3.449

5.  Striatal transcriptome changes linked to drug-induced repetitive behaviors.

Authors:  Jill R Crittenden; Theresa A Gipson; Anne C Smith; Hilary A Bowden; Ferah Yildirim; Kyle B Fischer; Michael Yim; David E Housman; Ann M Graybiel
Journal:  Eur J Neurosci       Date:  2021-03-23       Impact factor: 3.386

6.  Human methamphetamine pharmacokinetics simulated in the rat: behavioral and neurochemical effects of a 72-h binge.

Authors:  Ronald Kuczenski; David S Segal; William P Melega; Goran Lacan; Stanley J McCunney
Journal:  Neuropsychopharmacology       Date:  2009-07-01       Impact factor: 7.853

7.  Methylphenidate enhances NMDA-receptor response in medial prefrontal cortex via sigma-1 receptor: a novel mechanism for methylphenidate action.

Authors:  Chun-Lei Zhang; Ze-Jun Feng; Yue Liu; Xiao-Hua Ji; Ji-Yun Peng; Xue-Han Zhang; Xue-Chu Zhen; Bao-Ming Li
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

8.  CalDAG-GEFI mediates striatal cholinergic modulation of dendritic excitability, synaptic plasticity and psychomotor behaviors.

Authors:  Jill R Crittenden; Shenyu Zhai; Magdalena Sauvage; Takashi Kitsukawa; Eric Burguière; Morgane Thomsen; Hui Zhang; Cinzia Costa; Giuseppina Martella; Veronica Ghiglieri; Barbara Picconi; Karen A Pescatore; Ellen M Unterwald; Walker S Jackson; David E Housman; S Barak Caine; David Sulzer; Paolo Calabresi; Anne C Smith; D James Surmeier; Ann M Graybiel
Journal:  Neurobiol Dis       Date:  2021-08-08       Impact factor: 5.996

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.